Drug hepatotoxicity. (2014)
- Record Type:
- Book
- Title:
- Drug hepatotoxicity. (2014)
- Main Title:
- Drug hepatotoxicity
- Further Information:
- Note: Edited by Nicholaos Pyrsopoulos.
- Editors:
- Pyrsopoulos, Nicholaos
- Contents:
- Front Cover; Clinics in Liver Disease: Drug Hepatotoxicity; Copyright Page; Contributors; Table of Contents; CLINICS IN LIVER DISEASE; Preface; Chapter 1. Mechanisms of Drug-induced Liver Injury; KEYWORDS; KEY POINTS; NECROSIS, APOPTOSIS, AND NECROPTOSIS; THE INVOLVEMENT OF REACTIVE METABOLITES; INVOLVEMENT OF STRESS SIGNALING; THE INVOLVEMENT OF MITOCHONDRIAL DYSFUNCTION; THE INVOLVEMENT OF MITOCHONDRIAL ADAPTATION; THE ROLE OF ADAPTIVE IMMUNITY AND INNATE IMMUNITY IN DILI; SUMMARY; REFERENCES; Chapter 2. Drug-Induced Cholestasis; KEYWORDS; KEY POINTS; INTRODUCTION; EPIDEMIOLOGY. RISK FACTORSPATHOGENESIS; ASSOCIATION OF CAUSALITY; CLASSIFICATION OF DRUG-INDUCED CHOLESTASIS; ACUTE CHOLESTATIC DILI; CHRONIC CHOLESTATIC DILI; TREATMENT; PROGNOSIS; SUMMARY; REFERENCES; Chapter 3. Drug-Induced Steatohepatitis; KEYWORDS; KEY POINTS; DEFINITION OF NAFLD; DIAGNOSING DRUG-INDUCED STEATOHEPATITIS; PATHOGENESIS OF DRUG-INDUCED STEATOHEPATITIS; PATHOLOGIC SPECTRUM OF DRUG-INDUCED STEATOSIS AND STEATOHEPATITIS; MANAGEMENT OF PATIENTS WITH DRUG-INDUCED STEATOHEPATITIS; SUMMARY; REFERENCES; Chapter 4. Histopathologic Manifestations of Drug-induced Hepatotoxicity; KEYWORDS. KEY POINTSINTRODUCTION; HEPATOCELLULAR INJURY PATTERN; CHOLESTATIC INJURY PATTERN; STEATOSIS AND STEATOHEPATITIS PATTERN; GRANULOMA AND GRANULOMATOUS HEPATITIS; VASCULAR INJURY PATTERNS; CYTOPLASMIC INCLUSIONS, LIPIDOSIS, AND PIGMENTS; DRUG-INDUCED HEPATIC NEOPLASMS; SUMMARY; REFERENCES; Chapter 5. ClinicalFront Cover; Clinics in Liver Disease: Drug Hepatotoxicity; Copyright Page; Contributors; Table of Contents; CLINICS IN LIVER DISEASE; Preface; Chapter 1. Mechanisms of Drug-induced Liver Injury; KEYWORDS; KEY POINTS; NECROSIS, APOPTOSIS, AND NECROPTOSIS; THE INVOLVEMENT OF REACTIVE METABOLITES; INVOLVEMENT OF STRESS SIGNALING; THE INVOLVEMENT OF MITOCHONDRIAL DYSFUNCTION; THE INVOLVEMENT OF MITOCHONDRIAL ADAPTATION; THE ROLE OF ADAPTIVE IMMUNITY AND INNATE IMMUNITY IN DILI; SUMMARY; REFERENCES; Chapter 2. Drug-Induced Cholestasis; KEYWORDS; KEY POINTS; INTRODUCTION; EPIDEMIOLOGY. RISK FACTORSPATHOGENESIS; ASSOCIATION OF CAUSALITY; CLASSIFICATION OF DRUG-INDUCED CHOLESTASIS; ACUTE CHOLESTATIC DILI; CHRONIC CHOLESTATIC DILI; TREATMENT; PROGNOSIS; SUMMARY; REFERENCES; Chapter 3. Drug-Induced Steatohepatitis; KEYWORDS; KEY POINTS; DEFINITION OF NAFLD; DIAGNOSING DRUG-INDUCED STEATOHEPATITIS; PATHOGENESIS OF DRUG-INDUCED STEATOHEPATITIS; PATHOLOGIC SPECTRUM OF DRUG-INDUCED STEATOSIS AND STEATOHEPATITIS; MANAGEMENT OF PATIENTS WITH DRUG-INDUCED STEATOHEPATITIS; SUMMARY; REFERENCES; Chapter 4. Histopathologic Manifestations of Drug-induced Hepatotoxicity; KEYWORDS. KEY POINTSINTRODUCTION; HEPATOCELLULAR INJURY PATTERN; CHOLESTATIC INJURY PATTERN; STEATOSIS AND STEATOHEPATITIS PATTERN; GRANULOMA AND GRANULOMATOUS HEPATITIS; VASCULAR INJURY PATTERNS; CYTOPLASMIC INCLUSIONS, LIPIDOSIS, AND PIGMENTS; DRUG-INDUCED HEPATIC NEOPLASMS; SUMMARY; REFERENCES; Chapter 5. Clinical Manifestations and Treatment of Drug-induced Hepatotoxicity; KEYWORDS; KEY POINTS; EPIDEMIOLOGY; TERMINOLOGY; DIAGNOSIS; MANAGEMENT; REFERENCES; Chapter 6. Drug-induced Acute Liver Failure; KEYWORDS; KEY POINTS; BACKGROUND; ACETAMINOPHEN-RELATED ALF; IDIOSYNCRATIC DRUG-RELATED LIVER INJURY. OVERALL MANAGEMENTTRANSPLANTATION AND PROGNOSIS; GENOMICS AND THE FUTURE; SUMMARY; REFERENCES; Chapter 7. Acetaminophen-related Hepatotoxicity; KEYWORDS; KEY POINTS; INTRODUCTION; EPIDEMIOLOGY; PHARMACOLOGY AND HEPATOTOXICITY; FACTORS INFLUENCING APAP-RELATED HEPATOTOXICITY; CLINICAL MANIFESTATIONS; GENERAL APPROACH AND DIAGNOSTIC TOOLS; MANAGEMENT OF APAP OVERDOSE; REFERENCES; Chapter 8. Hepatotoxicity of Antibiotics: A Review and Update for the Clinician; KEYWORDS; KEY POINTS; INTRODUCTION; INCIDENCE OF ANTIBIOTIC DILI; INFECTIONS CAUSING JAUNDICE. PHARMACOGENOMICS, BIOMARKERS, AND ANTIBIOTIC DILIINDIVIDUAL ANTIMICROBIAL AGENTS: WHAT'S NEW?; ANTITUBERCULOSIS DRUGS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; ANTIPROTOZOAL AND ANTHELMINTIC AGENTS; ANTIBIOTIC USE IN CIRRHOSIS (INCLUDING TREATMENT OF SPONTANEOUS BACTERIAL PERITONITIS); SUMMARY; REFERENCES; Chapter 9. Nonsteroidal Anti-Inflammatory Drug-Induced Hepatoxicity; KEYWORDS; KEY POINTS; INTRODUCTION; DRUG-INDUCED LIVER INJURY; SEVERE HEPATOTOXICITY ASSOCIATED WITH NSAIDS; EPIDEMIOLOGY OF NSAID-INDUCED HEPATOTOXICITY; SUMMARY; REFERENCES. … (more)
- Publisher Details:
- Amsterdam : Elsevier
- Publication Date:
- 2014
- Extent:
- 1 online resource
- Subjects:
- 616.362071
Hepatotoxicology
Drugs -- Toxicology
Liver -- Effects of drugs on
HEALTH & FITNESS -- Diseases -- General
MEDICAL -- Clinical Medicine
MEDICAL -- Diseases
MEDICAL -- Evidence-Based Medicine
MEDICAL -- Internal Medicine
Electronic books - Languages:
- English
- ISBNs:
- 9780323261074
0323261078 - Related ISBNs:
- 9780323261067
032326106X - Notes:
- Note: Print version record.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.235890
- Ingest File:
- 01_153.xml